Pathstone Holdings’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120M Buy
274,275
+11,915
+5% +$3.62M 0.35% 51
2026
Q1
$56.1M Buy
262,360
+6,158
+2% +$1.38M 0.22% 71
2025
Q4
$43.9M Sell
256,202
-2,314
-0.9% -$360K 0.17% 87
2025
Q3
$34.6M Buy
258,516
+2,500
+1% +$265K 0.13% 107
2025
Q2
$25.1M Sell
256,016
-12,254
-5% -$972K 0.1% 135
2025
Q1
$19.5M Buy
268,270
+173,486
+183% +$13.7M 0.08% 175
2024
Q4
$6.85M Sell
94,784
-168,406
-64% -$12.8M 0.03% 440
2024
Q3
$21.5M Sell
263,190
-6,900
-3% -$600K 0.1% 157
2024
Q2
$28.8M Sell
270,090
-9,610
-3% -$922K 0.13% 111
2024
Q1
$27.2M Buy
279,700
+59,570
+27% +$5.24M 0.13% 115
2023
Q4
$17.4M Buy
+220,130
New +$15M 0.09% 155

Other funds holding LRCX

Pathstone Holdings's LRCX Position: Q2 2026 in Review

Pathstone Holdings increased its Lam Research (LRCX) stake by 4.5% in Q2 2026, buying an estimated $3.62M and bringing the position to 274,275 shares worth $120M. The position accounts for 0.35% of the portfolio, ranked #51.

Pathstone Holdings first reported a position in LRCX in Q4 2023 and has held it in 11 quarters since. 3,112 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Pathstone Holdings held 274,275 shares of Lam Research worth $120M as of Q2 2026.
  • Pathstone Holdings bought 11,915 Lam Research shares in Q2 2026, an estimated $3.62M.
  • Lam Research made up 0.35% of Pathstone Holdings's portfolio in Q2 2026, its #51 holding.
  • Pathstone Holdings first reported a position in Lam Research in Q4 2023 and has held it in 11 quarters since.
  • 3,112 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.